glp-1 and eating disorders #504: Adult in the Era Exclusive! #70: Adult Eating Disorders
Description
The dedicated cardiovascular outcomes trial (TRIUMPH-Outcomes), enrolling around 10,000 participants with established cardiovascular disease, chronic kidney disease, or high CV risk, is not expected to report until 2027 at the earliest [11]
The dashboard shows clear visualizations that help you spot patterns and see progress over time
Whether it happens or not, they're still being recommended: And if you don't see that as a problem, I can't help you
However, researchers soon realised its potential therapeutic use in humans as an anticoagulant
Ultimately, these actions are left up to shared decision-making
Gastrointestinal Symptoms : GLP-1 medications already slow gastric emptyingthats part of how they work
